India’s largest pharmaceutical company, Sun Pharmaceutical Industries has reported robust financial results for the financial year ended March 31, 2026, while also announcing a final dividend of ₹5 per equity share for shareholders.

Glenmark Pharmaceuticals announced that its US-based subsidiary, Glenmark Pharmaceuticals Inc., USA, has agreed to settle long-running antitrust litigation in the United States related to alleged price-fixing and anti-competitive practices in the generic drug market.

According to the company’s regulatory filing submitted to the stock exchanges, Glenmark USA will pay a total settlement amount of 29.628 million USD in annual instalments over five years. The settlement is still subject to approval by the court overseeing the litigation.

In a major breakthrough for liver disease treatment, Gilead Sciences has received accelerated approval from the U.S. FDA for Hepcludex (bulevirtide-gmod), making it the first and only approved therapy for chronic Hepatitis Delta Virus (HDV) infection in the United States.

Anusandhan National Research Foundation (ANRF) - established through an  Act of Parliament: ANRF Act, 2023, to provide high-level strategic directions for research, innovation, and entrepreneurship in the fields of natural sciences, including mathematical sciences, engineering and technology, environmental and earth sciences, health and agriculture, and scientific and technological interfaces of humanities and social sciences.

Applications are invited from eligible candidates for appointment to the 43 posts of Drugs lnspector (Medical Devices) Gazetted, Non-ministerial, Pay level 8 (Rs.47600-151 100) of 7th CPC in the Central Drugs Standard Control Organisation, Directorate General of Health Services, Ministry of Health & Family Welfare on deputation basis across all the zones/ sub-zones including Head Quarter under the CDSCO.

Post : Drugs Inspector

No of posts : 43